Company Performance Metrics
Erik Schaefer: Co-Founder, President, CEO, and CSO- Barbara Imperiali: Co-Founder and CTO
AssayQuant Technologies is a life science company that creates innovative enzyme assay formats for a quantum improvement in performance and productivity. AssayQuant's initial focus is on assays for measuring the activity of the >500 protein kinases, which are dysregulated in many disease states and comprise >30% of all drug development.
AssayQuant's PhosphoSens is a next-generation Sox-based sensor platform that uses proprietary technology invented in the Imperiali laboratory at MIT and is licensed to AssayQuant. This format provides a simple solution to quantitatively measure the activity of protein kinases and phosphatases, with specificity for Tyr, Ser/Thr, or Mixed Function, using a direct, one-step homogeneous, and continuous (kinetic) format.
